DCprime Competitors and Similar CompaniesClear all
GlycoMimetics's competitors and similar companies include TRACON Pharmaceuticals.
 GlycoMimetics GlycoMimetics is a biopharmaceutical company designing and developing small molecule therapeutics to treat various cancers. |  TRACON Pharmaceuticals TRACON Pharmaceuticals is a biopharmaceutical company focused on developing targeted therapies for cancer and macular degeneration. | |
Founding Date | Founding Date 2003 | Founding Date 2006 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Rockville, US HQ | Locations San Diego, US HQ |
Employees | Employees 5025% increase | Employees 268% increase |
Valuation ($) | Valuation ($) 31.6 m | Valuation ($) 279.4 k |
Financial | ||
Revenue (est.) | Revenue (est.) $10.8m (FY, 2025) | Revenue (est.) $12m (FY, 2023) |
Net income | Net income ($153.9m) (FY, 2025) | Net income ($3.6m) (FY, 2023) |
Funding | ||
Total funding raised | Total funding raised $ 101.8m | Total funding raised $ 41m |
For sources of this data, please see the company profile
View Company Profiles
TRACON Pharmaceuticals
HQ
San Diego, US
Employees
26↑ 8% increase
TRACON Pharmaceuticals is a biopharmaceutical company focused on developing targeted therapies for cancer and macular degeneration.
View company